Literature DB >> 16055710

Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.

Guillaume Bossis1, Cécile E Malnou, Rosa Farras, Elisabetta Andermarcher, Robert Hipskind, Manuel Rodriguez, Darja Schmidt, Stefan Muller, Isabelle Jariel-Encontre, Marc Piechaczyk.   

Abstract

The inducible transcriptional complex AP-1, composed of c-Fos and c-Jun proteins, is crucial for cell adaptation to many environmental changes. While its mechanisms of activation have been extensively studied, how its activity is restrained is poorly understood. We report here that lysine 265 of c-Fos is conjugated by the peptidic posttranslational modifiers SUMO-1, SUMO-2, and SUMO-3 and that c-Jun can be sumoylated on lysine 257 as well as on the previously described lysine 229. Sumoylation of c-Fos preferentially occurs in the context of c-Jun/c-Fos heterodimers. Using nonsumoylatable mutants of c-Fos and c-Jun as well as a chimeric protein mimicking sumoylated c-Fos, we show that sumoylation entails lower AP-1 transactivation activity. Interestingly, single sumoylation at any of the three acceptor sites of the c-Fos/c-Jun dimer is sufficient to substantially reduce transcription activation. The lower activity of sumoylated c-Fos is not due to inhibition of protein entry into the nucleus, accelerated turnover, and intrinsic inability to dimerize or to bind to DNA. Instead, cell fractionation experiments suggest that decreased transcriptional activity of sumoylated c-Fos is associated with specific intranuclear distribution. Interestingly, the phosphorylation of threonine 232 observed upon expression of oncogenically activated Ha-Ras is known to superactivate c-Fos transcriptional activity. We show here that it also inhibits c-Fos sumoylation, revealing a functional antagonism between two posttranslational modifications, each occurring within a different moiety of a bipartite transactivation domain of c-Fos. Finally we report that the sumoylation of c-Fos is a dynamic process that can be reversed via multiple mechanisms. This supports the idea that this modification does not constitute a final inactivation step that necessarily precedes protein degradation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16055710      PMCID: PMC1190241          DOI: 10.1128/MCB.25.16.6964-6979.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  69 in total

1.  The polycomb protein Pc2 is a SUMO E3.

Authors:  Michael H Kagey; Tiffany A Melhuish; David Wotton
Journal:  Cell       Date:  2003-04-04       Impact factor: 41.582

Review 2.  SUMO: a history of modification.

Authors:  Ronald T Hay
Journal:  Mol Cell       Date:  2005-04-01       Impact factor: 17.970

3.  Extracellular signal-regulated kinase 7 (ERK7), a novel ERK with a C-terminal domain that regulates its activity, its cellular localization, and cell growth.

Authors:  M K Abe; W L Kuo; M B Hershenson; M R Rosner
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

4.  The nuclear dot protein sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers.

Authors:  T Sternsdorf; K Jensen; B Reich; H Will
Journal:  J Biol Chem       Date:  1999-04-30       Impact factor: 5.157

5.  Redox factor-1 (Ref-1) mediates the activation of AP-1 in HeLa and NIH 3T3 cells in response to heat shock.

Authors:  D A Diamond; A Parsian; C R Hunt; S Lofgren; D R Spitz; P C Goswami; D Gius
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

6.  P300 transcriptional repression is mediated by SUMO modification.

Authors:  David Girdwood; Donna Bumpass; Owen A Vaughan; Alison Thain; Lisa A Anderson; Andrew W Snowden; Elisa Garcia-Wilson; Neil D Perkins; Ronald T Hay
Journal:  Mol Cell       Date:  2003-04       Impact factor: 17.970

7.  Phosphorylation of the carboxyl-terminal transactivation domain of c-Fos by extracellular signal-regulated kinase mediates the transcriptional activation of AP-1 and cellular transformation induced by platelet-derived growth factor.

Authors:  Paula Monje; Maria Julia Marinissen; J Silvio Gutkind
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

8.  Sumoylation is involved in beta-catenin-dependent activation of Tcf-4.

Authors:  Hideki Yamamoto; Motomasa Ihara; Yoshiharu Matsuura; Akira Kikuchi
Journal:  EMBO J       Date:  2003-05-01       Impact factor: 11.598

9.  Transcription factor phosphorylation by pp90(rsk2). Identification of Fos kinase and NGFI-B kinase I as pp90(rsk2).

Authors:  K D Swanson; L K Taylor; L Haung; A L Burlingame; G E Landreth
Journal:  J Biol Chem       Date:  1999-02-05       Impact factor: 5.157

10.  Sumoylation of the progesterone receptor and of the steroid receptor coactivator SRC-1.

Authors:  Anne Chauchereau; Larbi Amazit; Monique Quesne; Anne Guiochon-Mantel; Edwin Milgrom
Journal:  J Biol Chem       Date:  2003-01-14       Impact factor: 5.157

View more
  82 in total

Review 1.  Role of desumoylation in the development of prostate cancer.

Authors:  Jinke Cheng; Tasneem Bawa; Peng Lee; Limin Gong; Edward T H Yeh
Journal:  Neoplasia       Date:  2006-08       Impact factor: 5.715

2.  Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1/2 pathway-mediated phosphorylation of a unique C-terminal destabilizer.

Authors:  Jihane Basbous; Dany Chalbos; Robert Hipskind; Isabelle Jariel-Encontre; Marc Piechaczyk
Journal:  Mol Cell Biol       Date:  2007-03-19       Impact factor: 4.272

3.  SUMOylation of pontin chromatin-remodeling complex reveals a signal integration code in prostate cancer cells.

Authors:  Jung Hwa Kim; Ji Min Lee; Hye Jin Nam; Hee June Choi; Jung Woo Yang; Jason S Lee; Mi Hyang Kim; Su-Il Kim; Chin Ha Chung; Keun Il Kim; Sung Hee Baek
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-17       Impact factor: 11.205

4.  Virus infection triggers SUMOylation of IRF3 and IRF7, leading to the negative regulation of type I interferon gene expression.

Authors:  Toru Kubota; Mayumi Matsuoka; Tsung-Hsien Chang; Prafullakumar Tailor; Tsuguo Sasaki; Masato Tashiro; Atsushi Kato; Keiko Ozato
Journal:  J Biol Chem       Date:  2008-07-17       Impact factor: 5.157

Review 5.  The SUMO system: a master organizer of nuclear protein assemblies.

Authors:  Nithya Raman; Arnab Nayak; Stefan Muller
Journal:  Chromosoma       Date:  2013-08-06       Impact factor: 4.316

6.  Stress-induced phosphorylation of Thr486 in c-Myb by p38 mitogen-activated protein kinases attenuates conjugation of SUMO-2/3.

Authors:  Juraj Bies; Marek Sramko; Linda Wolff
Journal:  J Biol Chem       Date:  2013-11-20       Impact factor: 5.157

7.  Structure and promoter characterization of aldo-keto reductase family 1 B10 gene.

Authors:  Ziwen Liu; Linlin Zhong; Paulette A Krishack; Sarah Robbins; Julia X Cao; Yupei Zhao; Stephen Chung; Deliang Cao
Journal:  Gene       Date:  2009-02-21       Impact factor: 3.688

8.  SUMO Protease SMT7 Modulates Ribosomal Protein L30 and Regulates Cell-Size Checkpoint Function.

Authors:  Yen-Ling Lin; Chin-Lin Chung; Ming-Hui Chen; Chun-Han Chen; Su-Chiung Fang
Journal:  Plant Cell       Date:  2020-02-14       Impact factor: 11.277

9.  Ubiquitination of tombusvirus p33 replication protein plays a role in virus replication and binding to the host Vps23p ESCRT protein.

Authors:  Daniel Barajas; Peter D Nagy
Journal:  Virology       Date:  2009-12-09       Impact factor: 3.616

10.  Sumoylation controls host anti-bacterial response to the gut invasive pathogen Shigella flexneri.

Authors:  Sabrina Fritah; Nouara Lhocine; Filip Golebiowski; Joëlle Mounier; Alexandra Andrieux; Grégory Jouvion; Ronald T Hay; Philippe Sansonetti; Anne Dejean
Journal:  EMBO Rep       Date:  2014-08-05       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.